Kanovsky P - Search Results

1

Use of botulinum toxin type A in management of adult spasticity. A European consensus statement.

Ward AB, Aguilar M, De Beyl Z, Gedin S, Kanovsky P, Molteni F, Wissel J, Yakovleff A. Ward AB, et al. Among authors: kanovsky p. Eura Medicophys. 2004 Jun;40(2):83-4. Eura Medicophys. 2004. PMID: 16046931 Free article. No abstract available.

2

Use of botulinum toxin type A in management of adult spasticity--a European consensus statement.

Ward AB, Aguilar M, De Beyl Z, Gedin S, Kanovsky P, Molteni F, Wissel J, Yakovleff A. Ward AB, et al. Among authors: kanovsky p. J Rehabil Med. 2003 Mar;35(2):98-9. doi: 10.1080/16501970306112. J Rehabil Med. 2003. PMID: 12691340 Free article. No abstract available.

3

European consensus statement on the use of botulinum toxin type A in the management of adult spasticity.

Ward AB, Wissel J, Molteni F, Yakovleff A, Gedin S, Aguilar M, Kanovsky P, Zegers de Beyl D. Ward AB, et al. Among authors: kanovsky p. Acta Neurol Belg. 2003 Mar;103(1):39. Acta Neurol Belg. 2003. PMID: 12704982 Review. No abstract available.

4

Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study.

Wissel J, Kanovsky P, Ruzicka E, Bares M, Hortova H, Streitova H, Jech R, Roth J, Brenneis C, Müller J, Schnider P, Auff E, Richardson A, Poewe W. Wissel J, et al. Among authors: kanovsky p. J Neurol. 2001 Dec;248(12):1073-8. doi: 10.1007/s004150170028. J Neurol. 2001. PMID: 12013585 Clinical Trial.

5

Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.

Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, Pulte I. Kaňovský P, et al. J Rehabil Med. 2011 May;43(6):486-92. doi: 10.2340/16501977-0796. J Rehabil Med. 2011. PMID: 21533328 Free article. Clinical Trial.

6

Safety and efficacy of repeat long-term incobotulinumtoxinA treatment for lower limb or combined upper/lower limb spasticity in children with cerebral palsy.

Kaňovský P, Heinen F, Schroeder AS, Chambers HG, Dabrowski E, Geister TL, Hanschmann A, Martinez-Torres FJ, Pulte I, Banach M, Gaebler-Spira D. Kaňovský P, et al. J Pediatr Rehabil Med. 2022;15(1):113-127. doi: 10.3233/PRM-210041. J Pediatr Rehabil Med. 2022. PMID: 34957963 Free PMC article. Clinical Trial.

7

IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study.

Heinen F, Kanovský P, Schroeder AS, Chambers HG, Dabrowski E, Geister TL, Hanschmann A, Martinez-Torres FJ, Pulte I, Banach M, Gaebler-Spira D. Heinen F, et al. Among authors: kanovsky p. J Pediatr Rehabil Med. 2021;14(2):183-197. doi: 10.3233/PRM-210040. J Pediatr Rehabil Med. 2021. PMID: 34092664 Free PMC article. Clinical Trial.

8

Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.

Kanovský P, Bares M, Severa S, Richardson A; Dysport Paediatric Limb Spasticity Study Group. Kanovský P, et al. Dev Med Child Neurol. 2009 Jun;51(6):436-45. doi: 10.1111/j.1469-8749.2008.03264.x. Dev Med Child Neurol. 2009. PMID: 19563586 Free article. Clinical Trial.

9

A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

Benecke R, Jost WH, Kanovsky P, Ruzicka E, Comes G, Grafe S. Benecke R, et al. Among authors: kanovsky p. Neurology. 2005 Jun 14;64(11):1949-51. doi: 10.1212/01.WNL.0000163767.99354.C3. Neurology. 2005. PMID: 15955951 Clinical Trial.

10

Abnormalities of cortical excitability and cortical inhibition in cervical dystonia Evidence from somatosensory evoked potentials and paired transcranial magnetic stimulation recordings.

Kanovský P, Bares M, Streitová H, Klajblová H, Daniel P, Rektor I. Kanovský P, et al. J Neurol. 2003 Jan;250(1):42-50. doi: 10.1007/s00415-003-0942-2. J Neurol. 2003. PMID: 12527991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters